Diagnostic Nuclear Medicines Market to see Rapid Growth by 2029
Diagnostic Nuclear Medicines Market is anticipated to grow at a significant CAGR during the forecast period. Nuclear medicine uses small amounts of radioactive material called radiotracers, which are used to evaluate, diagnose, and treat various diseases. As far as their applications are concerned, diagnostic nuclear medicines hold quite promising opportunities in the field of oncology, and cardiology, among others. This is anticipated to be the major driving factor for market growth. Other key factors that can be attributed to the market growth include the rising prevalence and incidence of various chronic conditions such as cancer and cardiac ailments.
There have been recorded a substantial number of
mortalities due to cancer and CVDs which made it even more critical to look out
for early diagnostics and treatment solutions such as diagnostic nuclear
medicines. As per the WHO, in 2020, cancer was the leading cause of mortalities
globally, accounting for nearly 10 million mortalities. It is further estimated
that 19.3 million new yearly cancer cases are projected to be reported globally
by 2025. According to the WHO, globally, 17.9 million individuals died from
CVDs in 2019, accounting for 32% of the overall mortalities. This figure is
expected to reach 23.3 million by 2030. Thus, nuclear medicine’s role in
disease diagnosis and treatment can present opportunities for market growth
during the forecast period.
Some key players operating in the market include
Cardinal Health, GE Healthcare, Curium, Lantheus Medical Imaging, Bayer AG.
These players are eyeing to strengthen their position in the market by adopting
various strategies as mergers and acquisitions, partnerships, collaborations,
new product launch and development in the existing product portfolio, and so
on. For instance, in 2021, Bracco entered into a partnership with CardioNavix
which is aimed at improving patients’ approaches to cardiac PET imaging.
To Request a Sample of our Report on Diagnostic
Nuclear Medicines Market:
https://www.omrglobal.com/request-sample/diagnostic-nuclear-medicines-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2022-2030
·
Segment Covered
·
Regions Covered- Globally
Competitive Landscape: Cardinal Health, GE Healthcare, Curium, Lantheus
Medical Imaging, Bayer AG.
A
full Report of Diagnostic Nuclear Medicines Market is Available @ https://www.omrglobal.com/industry-reports/diagnostic-nuclear-medicines-market
Diagnostic Nuclear Medicines Market Report Segmentation
By Application
• Cardiology,
• Bone scans,
• Thyroid,
• Pulmonary scans,
• Others
Diagnostic Nuclear Medicines Market by Region
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request
for Report Customization @ https://www.omrglobal.com/report-customization/diagnostic-nuclear-medicines-market
About Orion Market Research
Orion Market Research (OMR) is a
market research and consulting company known for its crisp and concise reports.
The company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto
Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment